{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T08:14:35Z","timestamp":1783671275556,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum W\u00fcrzburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Inflammation plays a pivotal role in acute ischemic stroke (AIS), with neutrophil granulocytes acting as major contributors to the post-stroke immune response. Upon degranulation, neutrophils release matrix metalloproteinase-9 (MMP-9) and myeloperoxidase (MPO), both of which may influence functional outcomes following AIS. The aim of this study was to investigate the association between systemic levels of MMP-9 and MPO, functional outcome, and neutrophil counts in patients with moderate to severe AIS, with a focus on their pathophysiological relevance rather than standalone prognostic performance. This prospective single-center cohort study included patients with moderate to severe AIS in the anterior circulation (NIHSS score\u2009\u2265\u20096 points and \/or indication for mechanical recanalization). Venous blood was sampled in order to assess plasma concentrations of MMP-9 via zymography as well as MPO plasma levels via ELISA. Furthermore, differential blood count was determined simultaneously to venous biomarker sampling. Poor outcome was defined as mRS score\u2009\u2265\u20093. Uni- and multivariable regression analyses were performed. Between 07\/2020 and 09\/2022 a total of 279 patients with blood samples taken up to 48\u00a0h after symptom onset with a median NIHSS score of 13 and a median age of 79 were included. Of these patients, 81.0% underwent mechanical recanalization and 42.7% received systemic thrombolytic therapy. Systemic MMP-9 and MPO plasma levels were significantly higher in patients with poor functional outcome compared to patients with good functional outcome at 3-months (MMP-9: 359.1 vs. 303.5 ng\/ml,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0006; MPO: 27.0 vs. 19.2 ng\/ml,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0010). Both biomarkers were associated with a poor outcome in unadjusted analyses [MMP-9: unadjusted OR\u2009=\u200915.63 (95% CI: 3.54-80.69),\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0005; MPO: unadjusted OR\u2009=\u20094.02 (95% CI: 1.84-9.21),\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0007]. In addition, MMP-9 and MPO concentrations correlated with neutrophil counts (MMP-9:\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.39,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001; MPO:\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.31,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001). In conclusion, systemic MMP-9 and MPO plasma concentrations are associated with functional outcome in patients with moderate to severe AIS and reflect neutrophil-driven inflammatory processes. Their value appears to lie in complementing established clinical predictors rather than serving as independent prognostic markers.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-61410-z","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T07:24:40Z","timestamp":1783668280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Associations of plasma MMP-9 and MPO with functional outcome in moderate to severe acute ischemic stroke"],"prefix":"10.1038","volume":"16","author":[{"given":"Vivian","family":"Vogt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Vollmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Stoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe A.","family":"Montellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter U.","family":"Heuschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Kollikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Georg","family":"Haeusler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Neugebauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Schuhmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"issue":"2","key":"61410_CR1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1177\/17474930241308142","volume":"20","author":"VL Feigin","year":"2025","unstructured":"Feigin, V. L. et al. World Stroke Organization: Global Stroke Fact Sheet 2025. Int. J. Stroke. 20 (2), 132\u2013144. https:\/\/doi.org\/10.1177\/17474930241308142 (2025).","journal-title":"Int. J. Stroke"},{"issue":"9","key":"61410_CR2","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1177\/0271678X221105764","volume":"42","author":"G Stoll","year":"2022","unstructured":"Stoll, G., Schuhmann, M. K., Nieswandt, B., Kollikowski, A. M. & Pham, M. An intravascular perspective on hyper-acute neutrophil, T-cell and platelet responses: Similarities between human and experimental stroke. J. Cereb. Blood Flow. Metab. 42 (9), 1561\u20131567. https:\/\/doi.org\/10.1177\/0271678X221105764 (2022).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"61410_CR3","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154225","author":"F Denorme","year":"2022","unstructured":"Denorme, F. et al. Neutrophil extracellular traps regulate ischemic stroke brain injury. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI154225 (2022).","journal-title":"J. Clin. Invest."},{"issue":"1","key":"61410_CR4","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1038\/s41467-020-16191-y","volume":"11","author":"L Kang","year":"2020","unstructured":"Kang, L. et al. Neutrophil extracellular traps released by neutrophils impair revascularization and vascular remodeling after stroke. Nat. Commun. 11 (1), 2488. https:\/\/doi.org\/10.1038\/s41467-020-16191-y (2020).","journal-title":"Nat. Commun."},{"key":"61410_CR5","doi-asserted-by":"publisher","first-page":"106720","DOI":"10.1016\/j.phrs.2023.106720","volume":"190","author":"Y Ji","year":"2023","unstructured":"Ji, Y. et al. An MMP-9 exclusive neutralizing antibody attenuates blood-brain barrier breakdown in mice with stroke and reduces stroke patient-derived MMP-9 activity. Pharmacol. Res. 190, 106720. https:\/\/doi.org\/10.1016\/j.phrs.2023.106720 (2023).","journal-title":"Pharmacol. Res."},{"key":"61410_CR6","doi-asserted-by":"publisher","first-page":"105095","DOI":"10.1016\/j.ebiom.2024.105095","volume":"103","author":"AM Kollikowski","year":"2024","unstructured":"Kollikowski, A. M. et al. MMP-9 release into collateral blood vessels before endovascular thrombectomy to assess the risk of major intracerebral haemorrhages and poor outcome for acute ischaemic stroke: a proof-of-concept study. EBioMedicine 103, 105095. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105095 (2024).","journal-title":"EBioMedicine"},{"key":"61410_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2016.00056","author":"RJ Turner","year":"2016","unstructured":"Turner, R. J. & Sharp, F. R. Implications of MMP9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke. Front. Cell. Neurosci. https:\/\/doi.org\/10.3389\/fncel.2016.00056 (2016).","journal-title":"Front. Cell. Neurosci."},{"issue":"5S","key":"61410_CR8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1902\/jop.1993.64.5s.474","volume":"64","author":"H Birkedal-Hansen","year":"1993","unstructured":"Birkedal-Hansen, H. Role of Matrix Metalloproteinases in Human Periodontal Diseases. J. Periodontol. 64 (5S), 474\u2013484. (1993). https:\/\/doi.org\/10.1902\/jop.1993.64.5s.474","journal-title":"J. Periodontol"},{"issue":"11","key":"61410_CR9","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1097\/00004647-199811000-00001","volume":"18","author":"S Mun-Bryce","year":"1998","unstructured":"Mun-Bryce, S. & Rosenberg, G. A. Matrix Metalloproteinases in Cerebrovascular Disease. J. Cereb. Blood Flow. Metabolism. 18 (11), 1163\u20131172. https:\/\/doi.org\/10.1097\/00004647-199811000-00001 (1998).","journal-title":"J. Cereb. Blood Flow. Metabolism"},{"key":"61410_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","volume":"17","author":"MD Sternlicht","year":"2001","unstructured":"Sternlicht, M. D. & Werb, Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell. Dev. Biol. 17, 463\u2013516. https:\/\/doi.org\/10.1146\/annurev.cellbio.17.1.463 (2001).","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"issue":"3","key":"61410_CR11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/0003-9861(62)90321-1","volume":"96","author":"J Schultz","year":"1962","unstructured":"Schultz, J. & Kaminker, K. Myeloperoxidase of the leucocyte of normal human blood. I. Content and localization. Arch. Biochem. Biophys. 96 (3), 465\u2013467. https:\/\/doi.org\/10.1016\/0003-9861(62)90321-1 (1962).","journal-title":"Arch. Biochem. Biophys."},{"key":"61410_CR12","doi-asserted-by":"publisher","first-page":"149705","DOI":"10.1016\/j.brainres.2025.149705","volume":"1861","author":"W Liu","year":"2025","unstructured":"Liu, W., Wang, Y. R., Wu, H., Cui, W. & Xu, X. The role of myeloperoxidase in the pathogenesis of stroke. Brain Res. 1861, 149705. https:\/\/doi.org\/10.1016\/j.brainres.2025.149705 (2025).","journal-title":"Brain Res."},{"key":"61410_CR13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009179","author":"I Maestrini","year":"2020","unstructured":"Maestrini, I. et al. Analysis of the association of MPO and MMP-9 with stroke severity and outcome. Neurology https:\/\/doi.org\/10.1212\/WNL.0000000000009179 (2020).","journal-title":"Neurology"},{"key":"61410_CR14","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1212\/WNL.0000000000004257","volume":"89","author":"C Zhong","year":"2017","unstructured":"Zhong, C. et al. Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke. Neurology 89, 805\u2013812. https:\/\/doi.org\/10.1212\/WNL.0000000000004257 (2017).","journal-title":"Neurology"},{"issue":"4","key":"61410_CR15","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1177\/23969873241250272","volume":"9","author":"FA Montellano","year":"2024","unstructured":"Montellano, F. A. et al. Biomarkers to improve functional outcome prediction after ischemic stroke: Results from the SICFAIL, STRAWINSKI, and PREDICT studies. Eur. Stroke J. 9 (4), 968\u2013980. https:\/\/doi.org\/10.1177\/23969873241250272 (2024).","journal-title":"Eur. Stroke J."},{"issue":"2","key":"61410_CR16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1161\/STROKEAHA.120.029232","volume":"52","author":"FA Montellano","year":"2021","unstructured":"Montellano, F. A. et al. Role of Blood-Based Biomarkers in Ischemic Stroke Prognosis. Stroke 52 (2), 543\u2013551. https:\/\/doi.org\/10.1161\/STROKEAHA.120.029232 (2021).","journal-title":"Stroke"},{"key":"61410_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.036109","author":"S You","year":"2024","unstructured":"You, S. et al. Twenty-Four\u2010Hour Post\u2010Thrombolysis NIHSS Score As the Strongest Prognostic Predictor After Acute Ischemic Stroke: ENCHANTED Study. J. Am. Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.124.036109 (2024).","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"61410_CR18","doi-asserted-by":"publisher","first-page":"H558","DOI":"10.1152\/ajpheart.01275.2004","volume":"289","author":"JM Gidday","year":"2005","unstructured":"Gidday, J. M. et al. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am. J. Physiol. Heart Circ. Physiol. 289 (2), H558\u2013H. https:\/\/doi.org\/10.1152\/ajpheart.01275.2004 (2005).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"61410_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1189\/jlb.0907606","volume":"84","author":"E Cuadrado","year":"2008","unstructured":"Cuadrado, E. et al. Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release. J. Leukoc. Biol. 84 (1), 207\u2013214. https:\/\/doi.org\/10.1189\/jlb.0907606 (2008).","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"61410_CR20","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1476-5381.2009.00068.x","volume":"156","author":"S Gautier","year":"2009","unstructured":"Gautier, S., Ouk, T., Petrault, O., Caron, J. & Bordet, R. Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia. Br. J. Pharmacol. 156 (4), 673\u2013679. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00068.x (2009).","journal-title":"Br. J. Pharmacol."},{"key":"61410_CR21","doi-asserted-by":"publisher","first-page":"104790","DOI":"10.1016\/j.neuint.2020.104790","volume":"139","author":"R Kumari","year":"2020","unstructured":"Kumari, R., Bettermann, K., Willing, L., Sinha, K. & Simpson, I. A. The role of neutrophils in mediating stroke injury in the diabetic db\/db mouse brain following hypoxia-ischemia. Neurochem Int. 139, 104790. https:\/\/doi.org\/10.1016\/j.neuint.2020.104790 (2020).","journal-title":"Neurochem Int."},{"issue":"1","key":"61410_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0005-2744(78)90197-3","volume":"525","author":"A Bos","year":"1978","unstructured":"Bos, A., Wever, R. & Roos, D. Characterization and quantification of the peroxidase in human monocytes. Biochim. et Biophys. Acta (BBA) Enzymol. 525 (1), 37\u201344. (1978). https:\/\/doi.org\/10.1016\/0005-2744(78)90197-3","journal-title":"Biochim. et Biophys. Acta (BBA) Enzymol."},{"issue":"3","key":"61410_CR23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s12975-021-00938-w","volume":"13","author":"AM Kollikowski","year":"2022","unstructured":"Kollikowski, A. M. et al. Platelet Activation and Chemokine Release Are Related to Local Neutrophil-Dominant Inflammation During Hyperacute Human Stroke. Transl Stroke Res. 13 (3), 364\u2013369. https:\/\/doi.org\/10.1007\/s12975-021-00938-w (2022).","journal-title":"Transl Stroke Res."},{"issue":"1","key":"61410_CR24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s12035-021-02635-z","volume":"59","author":"C Li","year":"2022","unstructured":"Li, C. et al. Neutrophil Extracellular Traps Exacerbate Ischemic Brain Damage. Mol. Neurobiol. 59 (1), 643\u2013656. https:\/\/doi.org\/10.1007\/s12035-021-02635-z (2022).","journal-title":"Mol. Neurobiol."},{"key":"61410_CR25","doi-asserted-by":"publisher","first-page":"7724","DOI":"10.1523\/JNEUROSCI.21-19-07724.2001","volume":"21","author":"M Asahi","year":"2001","unstructured":"Asahi, M. et al. Effects of Matrix Metalloproteinase-9 Gene Knock-Out on the Proteolysis of Blood\u2013Brain Barrier and White Matter Components after Cerebral Ischemia. J. Neurosci. 21, 7724\u20137732. https:\/\/doi.org\/10.1523\/JNEUROSCI.21-19-07724.2001 (2001).","journal-title":"J. Neurosci."},{"issue":"8","key":"61410_CR26","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1038\/s41401-025-01505-x","volume":"46","author":"L Du","year":"2025","unstructured":"Du, L. et al. MMP-9 inhibitor SB-3CT improves neurological outcomes in ischemic stroke mice by modulation of astrocytic lipid metabolism. Acta Pharmacol. Sin. 46 (8), 2120\u20132135. https:\/\/doi.org\/10.1038\/s41401-025-01505-x (2025).","journal-title":"Acta Pharmacol. Sin"},{"issue":"2","key":"61410_CR27","doi-asserted-by":"publisher","first-page":"e1001380","DOI":"10.1371\/journal.pmed.1001380","volume":"10","author":"RD Riley","year":"2013","unstructured":"Riley, R. D. et al. Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research. PLoS Med. 10 (2), e1001380. https:\/\/doi.org\/10.1371\/journal.pmed.1001380 (2013).","journal-title":"PLoS Med."},{"key":"61410_CR28","doi-asserted-by":"publisher","first-page":"b606","DOI":"10.1136\/bmj.b606","volume":"338","author":"KGM Moons","year":"2009","unstructured":"Moons, K. G. M., Altman, D. G., Vergouwe, Y. & Royston, P. Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ 338, b606\u2013b. https:\/\/doi.org\/10.1136\/bmj.b606 (2009). jun04 2.","journal-title":"BMJ"},{"key":"61410_CR29","doi-asserted-by":"publisher","first-page":"e1001381","DOI":"10.1371\/journal.pmed.1001381","volume":"10","author":"EW Steyerberg","year":"2013","unstructured":"Steyerberg, E. W. et al. Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research. PLoS Med. 10, e1001381. https:\/\/doi.org\/10.1371\/journal.pmed.1001381 (2013). no. 2.","journal-title":"PLoS Med."},{"issue":"12","key":"61410_CR30","doi-asserted-by":"publisher","first-page":"29454","DOI":"10.3390\/ijms161226177","volume":"16","author":"MK Schuhmann","year":"2015","unstructured":"Schuhmann, M. K., Bittner, S., Meuth, S. G., Kleinschnitz, C. & Fluri, F. Fingolimod (FTY720-P) Does Not Stabilize the Blood-Brain Barrier under Inflammatory Conditions in an in Vitro Model. Int. J. Mol. Sci. 16 (12), 29454\u201329466. https:\/\/doi.org\/10.3390\/ijms161226177 (2015).","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"61410_CR31","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1161\/STROKEAHA.120.030287","volume":"51","author":"G Brugnara","year":"2020","unstructured":"Brugnara, G. et al. Multimodal Predictive Modeling of Endovascular Treatment Outcome for Acute Ischemic Stroke Using Machine-Learning. Stroke 51 (12), 3541\u20133551. (2020). https:\/\/doi.org\/10.1161\/STROKEAHA.120.030287.","journal-title":"Stroke"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61410-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61410-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61410-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T07:32:36Z","timestamp":1783668756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61410-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["61410"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-61410-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare the following financial interests\/personal relationships which may be considered as potential competing interests: Karl Georg Haeusler reports speaker\u2019s honoraria, consulting fees, lecture honoraria and\/or study grants from Abbott, Alexion, Amarin, AstraZeneca, Bayer Healthcare, Biotronik, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Medronic, Novartis, Pfizer, Portola, Premier Research, Sanofi, SUN Pharma, and W.L. Gore and Associates. Peter U. Heuschmann reports grants from German Ministry of Research and Education, German Research Foundation, European Union, Federal Joint Committee (G-BA) within the Innovationfond, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Berlin Chamber of Physicians, German Parkinson Society, University Hospital W\u00fcrzburg, Robert Koch Institute, German Heart Foundation, University G\u00f6ttingen (within FIND-AF [A Prospective, Randomised, Controlled Study to Determine the Detection of Atrial Fibrillation by Prolonged and Enhanced Holter Monitoring as Compared to Usual Care in Stroke Patients] randomized, supported by an unrestricted research grant to the University G\u00f6ttingen from Boehringer-Ingelheim), University Hospital Heidelberg (within Registry of Acute Stroke Under Novel Oral Anticoagulants [RASUNOA]-prime, supported by an unrestricted research grant to the University Hospital Heidelberg from Bayer, Bristol-Myers Squibb, Boehringer-Ingelheim, Daiichi Sankyo), grants from Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin (within MonDAFIS, supported by an unrestricted research grant to the Charit\u00e9 from Bayer), outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21612"}}